Andrew Schroeder, DO
Vascular Surgery · Omaha, NENPI 1902300510
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (52.4%), food and beverage and education — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Terumo Medical Corporation at 57.1% of the total. Reporting peaked in 2024 at $2,280 and has fallen 51.8% since, to $1,100 in 2025.
Across 41 payments — averaging $122.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Terumo Medical Corporation$3K
- Endologix LLC$488
- Medtronic$386
- Reflow Medical Inc$331
- W. L. Gore & Associates, Inc.$279
- Boston Scientific$238
- plus $444 from 8 others
What the payments were for
- Travel & lodging$2,64252%
- Food & beverage$2,17343%
- Education$2254%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Terumo Medical Corporation | 9 | $2,876 |
| Endologix LLC | 3 | $488 |
| Medtronic | 5 | $386 |
| Reflow Medical Inc | 3 | $331 |
| W. L. Gore & Associates, Inc. | 4 | $279 |
| Boston Scientific | 7 | $238 |
| Bard Peripheral Vascular, Inc. | 2 | $147 |
| Bolton Medical Inc | 1 | $137 |
| Immedica Pharma US, Inc. | 2 | $44 |
| Cordis US CORP. | 1 | $33 |
| Integra Lifesciences Corporation | 1 | $31 |
| BD | 1 | $20 |
| Edwards Lifesciences | 1 | $17 |
| Globus Medical | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,041 in reported general payments places this provider in the 55th percentile of 35 vascular surgery providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other vascular surgery in Omaha
- John ParkOmaha$508K
- David VogelOmaha$41K
- Marcus BaltersOmaha$27K
- Anjan TalukdarOmaha$25K
- Iraklis PipinosOmaha$24K
- Rao GuttaOmaha$21K
- Tammy RamosOmaha$10K
- Yue GaoOmaha$9K
- Jason CookOmaha$7K
- Katherine BrownOmaha$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.